High rate of sustained response to consensus interferon plus ribavirin in chronic hepatitis C patients resistant to alpha-interferon and ribavirin: a pilot study (2002)
- Authors:
- USP affiliated authors: SILVA, LUIZ CAETANO DA - FM ; NITA, SUZANE KIOKO ONO - FM ; CARRILHO, FLAIR JOSE - FM
- Unidade: FM
- DOI: 10.1007/s005350200119
- Subjects: INTERFERONS; HEPATITE C
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Journal of Gastroenterology
- Volume/Número/Paginação/Ano: v. 37, p. 732-736, 2002
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
SILVA, Luiz Caetano da et al. High rate of sustained response to consensus interferon plus ribavirin in chronic hepatitis C patients resistant to alpha-interferon and ribavirin: a pilot study. Journal of Gastroenterology, v. 37, p. 732-736, 2002Tradução . . Disponível em: https://doi.org/10.1007/s005350200119. Acesso em: 29 mar. 2024. -
APA
Silva, L. C. da, Bassit, L., Nita, S. K. O., Pinho, J. R. R., Nishiya, A., Madruga, C. L., & Carrilho, F. J. (2002). High rate of sustained response to consensus interferon plus ribavirin in chronic hepatitis C patients resistant to alpha-interferon and ribavirin: a pilot study. Journal of Gastroenterology, 37, 732-736. doi:10.1007/s005350200119 -
NLM
Silva LC da, Bassit L, Nita SKO, Pinho JRR, Nishiya A, Madruga CL, Carrilho FJ. High rate of sustained response to consensus interferon plus ribavirin in chronic hepatitis C patients resistant to alpha-interferon and ribavirin: a pilot study [Internet]. Journal of Gastroenterology. 2002 ; 37 732-736.[citado 2024 mar. 29 ] Available from: https://doi.org/10.1007/s005350200119 -
Vancouver
Silva LC da, Bassit L, Nita SKO, Pinho JRR, Nishiya A, Madruga CL, Carrilho FJ. High rate of sustained response to consensus interferon plus ribavirin in chronic hepatitis C patients resistant to alpha-interferon and ribavirin: a pilot study [Internet]. Journal of Gastroenterology. 2002 ; 37 732-736.[citado 2024 mar. 29 ] Available from: https://doi.org/10.1007/s005350200119 - High resistance to therapy in cirrhotic patients carrying HCV-RNA genotype 3
- High resistance to therapy in cirrhotic patients carrying HCV RNA genotype 3.
- Rapid and profound drop HCV RNA viremia induced by high dose of consensus IFN (CIFN) just before starting pegylated interferon (PEG-IFN) plus ribavirin (RBV) in chronic hepatitits C patients (pts) previously resistant to combined therapy (IFN+RBV): preliminary report
- Unpredictable outcome in lamivudine (LAM): resistant patients under high daily doses & early effects of combined therapy of lam plus pegylated interferon
- Tratamento da hepatite C
- Rapid and profound drop of HCV RNA viraemia induced by high dose of consensus interferon just before starting pegylated interferon plus ribavirin in chronic hepatitis C patients previously resistant to combined therapy:: preliminary report.
- A twelve-week period of follow-up after an end-of-treatment response in patients with chronic hepatitis C submitted to combined therapy is a reliable period to characterize a sustained response.
- A prospective study of the prevalence of hepatitis B and C virus co-infection among patients with chronic renal disease under hemodialysis
- Searching for chronic hepatitis B patients in a low prevalence area: role of racial origin
- A phylogenetic study of hepatitis B virus in chronically infected Brazilian patients of Western and Asian descent
Informações sobre o DOI: 10.1007/s005350200119 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas